MedTrace Logo

Advancing Community Level Action for Improving MCH/PMTCT

NCT01971710 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 187335

Last updated 2021-02-08

No results posted yet for this study

Summary

The goal of the ACCLAIM (Advancing Community-Level Action for Improving MCH/PMTCT) project is to increase community demand for, uptake of, and retention in Maternal and Child Health (MCH) and/Prevention of Mother-to-child transmission of HIV (PMTCT) services to improve country progress toward elimination of pediatric HIV/AIDS.

Conditions

Interventions

BEHAVIORAL

Community leader engagement

Community leaders conducting advocacy, community dialogue and community action plans on PMTCT/MCH

BEHAVIORAL

Community days

The provision of facilitated dialogues, advocacy and education, and selected health services, to a community on a specific day

BEHAVIORAL

Community Peer Groups

Pregnant women in community peer groups receiving information and education on PMTCT/MCH through 4 weekly peer-led classes . Men in community peer groups receiving information and education on their role in supporting women and families through 4 peer-led education sessions.

Sponsors & Collaborators

  • Canadian International Development Agency

    collaborator OTHER_GOV

  • Elizabeth Glaser Pediatric AIDS Foundation

    lead OTHER

Principal Investigators

  • Godfrey Woelk, PhD · Elizabeth Glaser Pediatric AIDS Foundation

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2015-12-31
Completion
2016-04-30

Countries

  • Eswatini
  • Uganda
  • Zimbabwe

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01971710 on ClinicalTrials.gov